Fundamentals

Valuation

Metric	Q4	Q2	Δ in %
EV/EBITDA	-100.00	-42.86	0.00
Graham Fair Price	100.00	0.07	0.00
PEG	0.00	0.00	0.00
Price/Book	-100.00	-1.29	0.00
Price/Cash Flow	-100.00	-7.47	0.00
Prices/Earnings	-100.00	-6.12	0.00
Price/Sales	100.00	146.13	0.00
Price/FCF	-100.00	-7.47	0.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q2	Δ in %
Gross Profit Margin	100.00	0.02	0.00
Operating Margin	-100.00	-6.67	0.00
ROA	n.A.	-0.28	n.A.
ROE	n.A.	0.05	n.A.
ROIC	n.A.	-1.43	n.A.
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q2	Δ in %
Debt QOQ	0.00	0.00	0.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.00	0.00	0.00
EPS QOQ	0.00	0.00	0.00
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	0.00	0.00	0.00
Naive Interpretation	member

03 - Financial Growth · Not Interpreted

Fundamentals

Leverage & Liquidity

Metric	Q4	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	243.12	100.00
Days Sales Outstanding (DSO)	0.00	101.92	100.00
Inventory Turnover	n.A.	0.37	n.A.
Debt/Capitalization	26.32	25.27	-4.00
Quick Ratio	0.51	0.71	38.94
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q2	Δ in %
Book Value	0.00	-0.07	-100.00
Cash	0.00	< 0.005	100.00
Capex	0.00	< 0.005	-100.00
Free Cash Flow	0.00	-0.01	-100.00
Revenue	0.00	< 0.005	100.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q2	Δ in %
Current Ratio	1.12	1.18	5.42
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.00	-19.93	-100.00
Naive Interpretation	Member

06 - Financial Health · Bad

Rating